Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular ...
Introduction Hepatocellular carcinoma (HCC) constitutes about 80% of primary liver cancers, with surgical resection as the main treatment, augmented by radiotherapy, targeted therapy, and immunotherapy.1–3 However, the prognosis for advanced HCC is poor …